Shilpa Medicare arm to make Sputnik V vaccine
The Hindu
Collaborates with Dr. Reddy’s, exploring option to manufacture Sputnik Lite
Shilpa Medicare has announced a collaboration with Dr. Reddy's Laboratories to produce Sputnik V, the Russian vaccine against COVID-19. Wholly-owned subsidiary Shilpa Biologicals has entered into a three year definitive agreement with Dr. Reddy's to manufacture Sputnik V vaccine from its integrated biologics research and development cum manufacturing centre in Dharwad, Karnataka, Shilpa Medicare said in a regulatory filing on Monday. The targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses (50 million of component 1 and 50 million of component 2), from the date of start of commercial production, the company said.More Related News